OpGen rises on R&D tie-up with diagnostics alliance FIND

CapForce

20/09/2022 13:34

** Diagnostics firm  OpGen Inc's  OPGN.O  shares rise 6.8% to
44 cents before the bell
    ** Co signs R&D collaboration agreement with FIND, a global
alliance for diagnostics, for Unyvero A30 RQ platform
 urn:newsml:reuters.com:*:nGNX2MLWqF
    ** Co is developing the platform to detect antimicrobial
resistance especially in low-middle income countries 
    ** Unyvero A30 RQ platform is an instrument that can detect
a broad range of microorganisms and antibiotic resistance
through single test
    ** Up to Monday's close, stock down ~58% YTD 

 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))